Sign in

CIK 0001818382 · Non-accelerated filer<br>Smaller reporting company

Humacyte, Inc.

Sign in to watch
Ticker
HUMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
851763759
Phone
919-313-9633
Business address
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
Former names
Alpha Healthcare Acquisition Corp.
  1. 4 Open-market sale President, CEO and Director sold 1,522,500 shares at $4.00 ($6,090,000)
  2. 4 Open-market sale Director sold 1,522,500 shares at $4.00 ($6,090,000)
  3. 4 Open-market sale 10% owner sold 1,522,500 shares at $4.00 ($6,090,000)
  4. EFFECT Other Notice of Effectiveness
  5. POS AM Other Post-effective Amendment for Registration Statement
  6. EFFECT Other Notice of Effectiveness
  7. EFFECT Other Notice of Effectiveness
  8. 424B3 Offering Prospectus
  9. 424B3 Offering Prospectus
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. CORRESP Other Correspondence Between Filers and SEC Staff
  12. UPLOAD Other SEC-generated Letter
  13. UPLOAD Other SEC-generated Letter
  14. 4 Open-market buy Director bought 61,841 shares at $4.40 ($272,100)
  15. 4 Open-market buy Director bought 48,159 shares at $4.00 ($192,636)
  16. S-3 Offering Registration Statement
  17. S-3 Offering Registration Statement
  18. 424B3 Offering Prospectus
  19. 10-Q Report Quarterly Report
  20. 8-K Event Results of operations

Page 17 of 26 · 506 filings